ConductScience.org, home

Cell line · CVCL_0460

Papers53

2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

PaperJournalYearHow we knowRetractedSource
Integrative genomics and experimental validation identify a mechanosensitive gene signature associated with colorectal cancer liver metastasis.iScience2026Its Methods give the RRID and name the linePubMed
Identification of Immuno-Diagnostic and Therapeutic Markers in Tumors and Inflammatory Diseases Based on Single-Cell and Machine Learning Methods.Hum Mutat2026Its Methods give the RRID and name the linePubMed
MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Bletilla striata polysaccharide as a form-dictating carrier enhances the local efficacy of low-dose 5-aminosalicylic acid for intestinal mucosal healing.Biomater Biosyst2026Its Methods give the RRID and name the linePubMed
Lactobacillus salivarius potentiates gastrointestinal cancer immunotherapy through its metabolite chenodeoxycholic acid.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Synthesis and biological evaluation of oridonin derivatives as antiproliferative agents against colorectal cancer.RSC Med Chem2026Its Methods give the RRID and name the linePubMed
An epithelial-mesenchymal transition-related gene signature predicts prognosis, immune infiltration, and drug sensitivity in colorectal cancer.Cancer Drug Resist2026Its Methods give the RRID and name the linePubMed
GPR39 Suppresses Ferroptosis via the Nrf2/SLC7A11 Axis and Reduces the Sensitivity of Colorectal Cancer to Anti-PD-1 Immunotherapy.Can J Gastroenterol Hepatol2026Its Methods give the RRID and name the linePubMed
Gene expression adaptation of metastases to their host tissue.iScience2026Its Methods give the RRID and name the linePubMed
Hollow Cu2O Nanozymes Enhance Probiotic Therapy for Colitis via Redox Homeostasis and TXNIP/NLRP3 Inflammasome Inhibition.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
RBMX promotes colorectal liver metastasis by stabilizing MTHFD2 mRNA to regulate redox homeostasis.Cell Mol Life Sci2026Its Methods give the RRID and name the linePubMed
Multi-Component Functionalized Bifidobacterium Longum Hydrogel for Multi-Target Integrated Therapy of Colitis-Associated Anxiety and Depression.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Methyltransferase-like 3/14-mediated m6A Silencing of GPx3 Drives Lipophagy Dysfunction and Ferroptosis Resistance in Colorectal Cancer.Research (Wash D C)2026Its Methods give the RRID and name the linePubMed
Identification and Experimental Verification Reveal SLC2A3 Associated With Prognosis and Immune Infiltration in Colon Adenocarcinoma.Mediators Inflamm2026Its Methods give the RRID and name the linePubMed
ASCL2 drives colorectal cancer metastasis through transcriptional activation of TDGF1.Cell Oncol (Dordr)2026Its Methods give the RRID and name the linePubMed
EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS-STING Pathway.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
ETV4 Promotes Colorectal Cancer Progression by Reprogramming Asparagine Metabolism to Remodel the Stromal Microenvironment.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Targeting NAT10 alleviates colonic senescence and elderly-onset colitis by disrupting N4-acetylation of DYRK1A.Nat Commun2026Its Methods give the RRID and name the linePubMed
Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer.Cancer Res2026Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0460/papers